Home โบ Blood Clots
Blood Clots clinical trials recruiting in the U.S.
36 studies for Blood Clots are recruiting participants at sites across the United States.
Your blood forms clots to stop bleeding. Some people get too many clots or their blood clots abnormally. Learn about the causes and treatments.
Cities with the most studies
- Boston, MA9 studies
- Houston, TX7 studies
- Atlanta, GA7 studies
- Washington, DC6 studies
- New York City, NY5 studies
- Simi Valley, CA4 studies
- Amarillo, TX4 studies
- San Diego, CA4 studies
- Tampa, FL4 studies
- Little Rock, AR4 studies
- Chicago, IL4 studies
- Dothan, AL3 studies
- Sarasota, FL3 studies
- Huntington Beach, CA3 studies
- Fremont, CA3 studies
- Ventura, CA3 studies
- Johns Creek, GA3 studies
- Concord, NC3 studies
- Pasadena, CA3 studies
- Farmington Hills, MI3 studies
- Monroe, LA3 studies
- Sugar Land, TX3 studies
- Hammond, IN3 studies
- Marion, OH3 studies
- Kendall, FL3 studies
- Cleveland, OH3 studies
- Cincinnati, OH3 studies
- Norfolk, VA3 studies
- Detroit, MI3 studies
- Indianapolis, IN3 studies
- Orlando, FL3 studies
- Toledo, OH3 studies
- Plano, TX3 studies
- Seattle, WA3 studies
- Dallas, TX3 studies
- Los Angeles, CA3 studies
- Cedar Rapids, IA3 studies
- Nashville, TN3 studies
- Columbus, OH3 studies
By state
- Alabama7 studies
- Arizona5 studies
- Arkansas4 studies
- California9 studies
- Connecticut3 studies
- Florida9 studies
- Georgia7 studies
- Illinois5 studies
- Indiana7 studies
- Iowa3 studies
- Louisiana7 studies
- Maryland10 studies
- Massachusetts9 studies
- Michigan6 studies
- New Jersey4 studies
- New York12 studies
- North Carolina9 studies
- Ohio8 studies
- Pennsylvania4 studies
- Tennessee7 studies
- Texas10 studies
- Virginia5 studies
- Washington3 studies
Recently updated studies
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 28, 2026 ยท NCT07175428Aspiration Thrombectomy Using the Symphony or Prodigy System
RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07350499Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
RecruitingPhase 2
Ages 18 to 89 ยท All sexes ยท Updated Sep 25, 2026 ยท NCT04862468Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 25, 2026 ยท NCT07318610Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
RecruitingObservational study
1 Month โ 80 Years ยท All sexes ยท Updated Sep 22, 2026 ยท NCT02089789Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 17, 2026 ยท NCT07430956Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease
Recruiting
Ages 18 and older ยท All sexes ยท Updated Sep 11, 2026 ยท NCT07613840Controls and Healthy Vasculature Initiative
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 90 ยท All sexes ยท Updated Sep 4, 2026 ยท NCT05403151Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 31, 2026 ยท NCT07498517ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RecruitingObservational study
All ages ยท All sexes ยท Updated Aug 17, 2026 ยท NCT04398628Rapid Evacuation and Access of Cerebral Hemorrhage Trial
Recruiting
Ages 18 to 70 ยท All sexes ยท Updated Aug 14, 2026 ยท NCT06870812Case-Specific Health Care Professional Clinical Survey of Liberantโข Thrombectomy System
RecruitingObservational study
Ages 22 and older ยท All sexes ยท Updated Aug 11, 2026 ยท NCT07335341Platelet Volunteers, Longitudinal and Multi-omic Study
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 100 ยท All sexes ยท Updated Jul 31, 2026 ยท NCT07137429[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Jul 21, 2026 ยท NCT07560306Evaluation of the Pathobiology of CALR-mutated MPN Cells
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Jul 13, 2026 ยท NCT06480591Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
Recruiting
Ages 65 to 84 ยท All sexes ยท Updated Jun 8, 2026 ยท NCT05867381Michigan Initial Experience Using Tigertriever for Thrombectomy
RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated May 8, 2026 ยท NCT07363525Study to Evaluate CAY001 in Healthy Volunteers
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 50 ยท All sexes ยท Updated May 5, 2026 ยท NCT06845839ATHNdataset Registry
RecruitingObservational study
All ages ยท All sexes ยท Updated Apr 21, 2026 ยท NCT06820515Apixaban in Thrombocytopenia
RecruitingEarly phase 1
Ages 18 and older ยท All sexes ยท Updated Apr 15, 2026 ยท NCT06886516Neonatal Platelet Transfusion Threshold Trial
RecruitingHealthy volunteers welcome
1 Hour โ 48 Hours ยท All sexes ยท Updated Mar 25, 2026 ยท NCT06676904The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
RecruitingObservational study
Ages 18 to 120 ยท All sexes ยท Updated Mar 5, 2026 ยท NCT04947657Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
RecruitingPhase 4
Ages 18 and older ยท All sexes ยท Updated Feb 27, 2026 ยท NCT06655376Positron Emission Tomography (PET) Imaging of Thrombosis
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 ยท All sexes ยท Updated Feb 27, 2026 ยท NCT03830320From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.